Sera Prognostics, Inc.
HealthcareNASDAQ:SERA · NASDAQ Global Market
-$0.06 today
Vol 0.05M · Avg 0.07M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+9.36%
Period High
$4.09
Period Low
$1.59
Latest
$1.87
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Apyx Medical Corporation
NASDAQ:APYX
$196.39M
Surrozen, Inc.
NASDAQ:SRZN
$174.90M
TuHURA Biosciences, Inc.
NASDAQ:HURA
$147.74M
Lucid Diagnostics Inc.
NASDAQ:LUCD
$98.28M
Cognition Therapeutics, Inc.
NASDAQ:CGTX
$89.03M
Oncolytics Biotech Inc.
NASDAQ:ONCY
$80.59M
Rapid Micro Biosystems, Inc.
NASDAQ:RPID
$79.77M
SkyAI, Inc.
STSS
$47.61M
Tevogen Bio Holdings Inc.
TVGN
$43.84M
Atossa Therapeutics, Inc.
ATOS
$21.18M
What is the latest SERA filing?
The latest filing shown is 4 dated Jun 10, 2026.
How many recent filings does SERA have?
Intrinsic Alpha currently shows 20 recent filings for SERA.
Explore More
Continue the stock analysis
Jump to another research area for this company.